A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease.
about
Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia.Discovery of butyrylcholinesterase inhibitors among derivatives of azaphenothiazines.Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer's Agents: Design, Synthesis and Biological Evaluation.Cholinergic depletion and basal forebrain volume in primary progressive aphasia.Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia.Cholinesterase and Prolyl Oligopeptidase Inhibitory Activities of Alkaloids from Argemone platyceras (Papaveraceae).Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment.Discovery of novel choline acetyltransferase inhibitors using structure-based virtual screening.Proline-Based Carbamates as Cholinesterase Inhibitors.Development of 2-Methoxyhuprine as Novel Lead for Alzheimer's Disease Therapy.Synthesis, Biological Evaluation and Molecular Modelling of 2'-Hydroxychalcones as Acetylcholinesterase Inhibitors.Profiling donepezil template into multipotent hybrids with antioxidant properties.Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation
P2860
Q33596451-34E7C1B9-61A3-4EEB-B329-984DD6DE0220Q35130541-BC2BB0AD-3B09-4930-9985-0F207524CD2DQ36407216-9CA8B517-048A-44D0-A735-C572003A2D70Q38383122-BF936A61-E40A-48DE-8CB8-67DF2FB25977Q38661735-3C3F2760-B9FA-4AD7-98F3-DA0BC58E0B10Q38679235-56FDA4DF-F5A6-4D56-A31A-228845B8E1ADQ42293352-4063B09A-FDA7-4ECF-BCF7-0FCE4E67985EQ47111224-F1241881-CCEA-45AB-82A9-E5D7B50C3C8AQ47600197-687E0646-E5E1-457D-82A5-95B33B84DDE4Q47651680-00E5F7BA-A93A-4608-988F-6230D98664FFQ51618214-61E7F235-A929-412C-91DE-0B6393F4C315Q52660268-C9B4DF9B-C826-4522-9A9D-CD4B8F6BA73AQ58700158-770D27F3-40A1-422D-A91D-FC0AF7C141CA
P2860
A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A review of butyrylcholinester ...... atment of Alzheimer's disease.
@en
A review of butyrylcholinester ...... atment of Alzheimer's disease.
@nl
type
label
A review of butyrylcholinester ...... atment of Alzheimer's disease.
@en
A review of butyrylcholinester ...... atment of Alzheimer's disease.
@nl
prefLabel
A review of butyrylcholinester ...... atment of Alzheimer's disease.
@en
A review of butyrylcholinester ...... atment of Alzheimer's disease.
@nl
P2093
P2860
P356
P1476
A review of butyrylcholinester ...... atment of Alzheimer's disease.
@en
P2093
Monique Somogyi
Roger Bullock
Taher Darreh-Shori
P2860
P356
10.4088/PCC.12R01412
P577
2013-03-07T00:00:00Z